Kernicterus pp 161-173 | Cite as

Hyperbilirubinemia Revisited

Chapter
Part of the Contemporary Clinical Neuroscience book series (CCNE)

Abstract

In recent years there have been numerous papers published reexamining various concepts regarding unconjugated bilirubin and its apparent toxicity. Overall, results of these studies have shown that measurement of serum levels of unconjugated, conjugated, and/or total bilirubin may not be adequate for assessing the risk for kernicterus in newborn jaundiced infants. Especially measuring total bilirubin does not assess the contribution of unconjugated and conjugated bilirubin. It is assumed that in newborn infants the majority is unconjugated. Also not evaluated by either method is the contribution of “free” unbound to albumin bilirubin. It is this moiety of bilirubin, free and unbound to albumin which can move easily and rapidly into brain tissue.

Keywords

Toxicity Albumin Glutathione Lipase Schizophrenia 

References

  1. Ahlfors, C. (2000) Measurement of plasma unbound unconjugated bilirubin. Anal. Biochem. 279:130–135PubMedCrossRefGoogle Scholar
  2. Bayon, J., et al. (2001) Pitfalls in preparation of unconjugated bilirubin by biosynthetic labeling from precursor H-5-aminolevulinic acid in the dog. J. Lab. Clin. Med. 138:313–321PubMedCrossRefGoogle Scholar
  3. Clegg, L., and Lindup, W. (1984) J. Pharm. Pharmacol. Phenobarbitol in hyperbilirubinemia. 36:776–779PubMedCrossRefGoogle Scholar
  4. Cole, S., et al. (1992) Over expression of a transporter gene in a multidrug resistant human lung cancer cell line. Science 258:1650–1654PubMedCrossRefGoogle Scholar
  5. Fenerty, C., and Lindup, W. (1989) Brain uptake of L-tryptophan and diazepam: The role of Plasma protein binding. J. Neurochem. 53:416–422PubMedCrossRefGoogle Scholar
  6. Gennuso, F., et al. (2004) Bilirubin protects astrocytes from its own toxicity by inducing up regulation and translocation of multidrug resistance associated protein 1. Proc. Natl. Acad. Sci. 101:2470–2475PubMedCrossRefGoogle Scholar
  7. Hahm, J., et al. (1992) Ionization and self association of unconjugated bilirubin determined by rapid solvent partition from chloroform with further studies of bilirubin solubility. J. Lipid Res. 33:1123–1137PubMedGoogle Scholar
  8. Hopkins, P., et al. (1996) Higher serum bilirubin isassociated with decreased risk for familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 16:250–255PubMedCrossRefGoogle Scholar
  9. Jedlitschky, G., et al. (1997) ATP dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem. J. 327:305–310PubMedGoogle Scholar
  10. Liu, Y., et al. (2003) Bilirubin as a potent antioxident supresses experimental autoimmune encephalomyelitis. J. Neuroimmunol. 139:27–35PubMedCrossRefGoogle Scholar
  11. Mao, Q., Deeley, R., and Cole, S. (2000) Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 in phospholipid vesicles. J. Biol. Chem. 275:34166–34172PubMedCrossRefGoogle Scholar
  12. Mukerjee, P., Ostrow, J., and Tiribelli, C. (2002) Low solubility of unconjugated bilirubin in dimethylsulfoxide water systems: implications for pKa determinations. BMC Biochem. 3:17–26PubMedCrossRefGoogle Scholar
  13. Muller, N., et al. (1991) Coincidence of schizophrenia and hyperbilirubinemia. Pharmacopsych. 24:225–228CrossRefGoogle Scholar
  14. Ostrow, J., and Tiribelli, C. (2003) Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr. Res. 54: 98–104PubMedCrossRefGoogle Scholar
  15. Pascolo, L., et al. (1998) ATP dependent transport of unconjugated bilirubin by rat liver canalicular plasma membrane vesicles. Biochem. J. 331:99–103PubMedGoogle Scholar
  16. Sugama, S., Soeda, A., and Eto, Y. (2001) Magnetic resonance imaging in three children with kernicterus. Pediatr. Neurol. 25:328–331PubMedCrossRefGoogle Scholar
  17. Weisiger, R., et al. (2001) Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition. J. Biol. Chem. 276:29953–29960PubMedCrossRefGoogle Scholar
  18. WHO Severe and complicated malaria: A report of the WHO malaria action programme. Trans. R. Soc. Med. Hyg. 80:1–50Google Scholar
  19. Wu, T., et al. (1994) Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sci. 54:477–481Google Scholar
  20. Rigato, I., et al. (2004) The human multidrug resistance associated protein MRP1 mediates ATP dependent transport of unconjugated bilirubin. Biochem. J. 383:335–341PubMedCrossRefGoogle Scholar
  21. Ostrow, J., Hammaker, L., and Schmid, R. (1961) The preparation of crystalline bilirubin. J. Clin. Invest. 60:1442–1452CrossRefGoogle Scholar
  22. Ostrow, J., et al. (2003) New concepts in bilirubin encephalopathy. Europ. J. Clin. Med. 33:988–997Google Scholar
  23. Ostrow, J. Pascolo, L., and Tiribelli, C. (2003) Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr. Res. 54:98–104PubMedCrossRefGoogle Scholar
  24. Rigato, I., Ostrow, J., and Tiribelli, C. (2005) Bilirubin and the risk of common non-hepatic diseases. Trends mol. Med. 11:277–283PubMedCrossRefGoogle Scholar
  25. McDonagh, A., and Maisels, M. (2006) Bilirubin unbound: déjà vu all over again. Pediatr. 117:523–525CrossRefGoogle Scholar
  26. Ostrow, and Mukerjee, P. (2007) Revalidation and rationale for high pKa values of unconjugated bilirubin. BMC biochem. 8:7–19PubMedCrossRefGoogle Scholar
  27. McCoy, D. (1967) Spontaneous rupture of the liver in a case of sclerodermia. J. Irish Med. Assocn. 60:474–484Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Cell Biology & AnatomyRosalind Franklin University of Medicine & Science, Chicago Medical SchoolNorth ChicagoUSA

Personalised recommendations